Elbow / Medial Epicondylitis / Shockwave / VAS+PREE

This Circle helps physicians capture and monetize real-world data from their everyday delivery of Shockwave for Medial Epicondylitis.  

The Shockwave Market was valued at $1.34 Billion in 2023, and is estimated to grow to $2.4 Billion by 2030. Medial Epicondylitis is a common indication among adult men and women, ages 30 to 50. It is often treated with Shockwave. Manufacturers will thus increasingly spend on obtaining and maintaining regulatory approvals for marketing those products for Medial Epicondylitis. Increasingly, that spending will be focused on licensing real-world safety and efficacy data from their everyday customers.

This Circle helps physicians obtain and aggregate those high quality real-world data those companies are looking for. Participation is minimally burdensome, and members will receive recurring license fees once obtained and in accordance with their contribution of Medial Epicondylitis cases, outcomes and other case data.